Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tabletsESGB150 mg / 200 mg / 245 mgGilead Sciences Ireland Unlimited Company
elvitegravir + cobicistat + emtricitabina + tenofovirES150 mg / 200 mg / 245 mgGilead Sciences Ireland Unlimited Company
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarateUS150 mg / 200 mg / 300 mgGilead Sciences, Inc.
elvitegravir + cobicistat + tenofovir disoproxil fumarate + emtricitabineAU——
STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottleAU300 mg / 200 mg / 150 mgGilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.